Описание деятельности
PharmaSGP is a pure-play consumer health company with a broad portfolio of leading chemical-free non-prescription pharmaceuticals sold over the counter (“OTC”) and other healthcare products. PharmaSGP’s products are sold exclusively through pharmacies. Its products are based on natural active pharmaceutical ingredients with documented efficacy and fewer known side effects than most chemical-based pharmaceuticals. The Company’s core brands cover chronic indications, including pain and other age-related ailments. In Germany, PharmaSGP is the market leader for systemic chemical-free pain remedies with its brand families RUBAXX® for rheumatic pain and RESTAXIL® for neuralgic pain. Furthermore, PharmaSGP has introduced leading products against sexual weakness and vertigo symptoms.
Правление & Наблюдательный совет
Исполнительный директор |
Natalie Weigand |
Правление |
Michael Rudolf |
Наблюдательный совет |
Dr. Clemens Fischer, Madlena Hohlefelder, Dr. Axel Rebien |
Данные компании
Имя: |
PharmaSGP Holding SE |
Адрес: |
Lochhamer Schlag 21,D-82166 Gräfelfing |
Телефон: |
+49-611-2058-5528 |
Факс: |
+49-611-2058-5566 |
E-mail: |
info@pharmasgp.com
|
Интернет: |
https://pharmasgp.com/ |
Индустрия: |
Healthcare |
Сектор: |
Pharmaceutical Industry |
Подсектор: |
Pharmaceuticals |
Конец финансового года: |
31.12 |
Акции в свободном обращении: |
- |
Дата IPO: |
19.06.2020 |
Связи с инвесторами
Имя: |
Claudius Krause |
IR телефон: |
+49-611-2058-5535 |
IR-факс: |
- |
IR e-mail: |
ir@pharmasgp.com
|